T1	Participants 0 20	Bronchial carcinoma.
T2	Participants 138 180	inoperable patients with advanced disease.
T3	Participants 182 285	Forty-eight bronchial carcinoma patients in clinicoanatomical stage 4 of the disease (advanced disease)
T4	Participants 291 308	randomly assigned
T5	Participants 312 318	groups
